Literature DB >> 20693812

Low iPTH can predict vascular and coronary calcifications in patients undergoing peritoneal dialysis.

Sun Chul Kim1, Hye Won Kim, Se Won Oh, Ha Na Yang, Myung-Gyu Kim, Sang-Kyung Jo, Won Yong Cho, Hyoung Kyu Kim.   

Abstract

BACKGROUND: There is substantial evidence that low levels of serum intact parathyroid hormone (iPTH) are associated with vascular calcium deposition and subsequent increased cardiovascular risk in chronic kidney disease patients. The purpose of this study was to determine the relationship between the serum iPTH level, and vascular and coronary artery calcifications (VCs, CACs) and arterial stiffness in peritoneal dialysis (PD) patients.
METHODS: In this cross-sectional study, 93 PD patients were included. VCs, CACs and arterial stiffness were measured by simple X-rays of the hands and pelvis, multi-slice coronary CT and brachial-ankle pulse wave velocity (BaPWV).
RESULTS: Patients were divided into 3 groups according to iPTH levels. The prevalence of severe VCs (VC score ≥ 3) was highest in the low iPTH group (<150 pg/ml). In multivariate analysis, the presence of diabetes mellitus and a low iPTH were shown to be significant risk factors for severe VCs. In addition, a simple VC score of ≥ 1 was a significant variable for predicting severe CACs (CAC score ≥ 400).
CONCLUSION: Low iPTH and the presence of diabetes mellitus are thought to be independent risk factors for predicting VCs. VCs determined by simple X-ray can further predict the coexistence of CACs that ultimately might contribute to increased cardiovascular risk in PD patients.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693812     DOI: 10.1159/000319658

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  7 in total

1.  Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients.

Authors:  Sun Chul Kim; Hyo Jung Chang; Myung-Gyu Kim; Sang-Kyung Jo; Won-Yong Cho; Hyoung-Kyu Kim
Journal:  Kidney Res Clin Pract       Date:  2015-01-30

2.  Aortic Arch Calcification Predicts Patency Loss of Arteriovenous Fistula in End-Stage Renal Disease Patients.

Authors:  Yit-Sheung Yap; Kai-Ting Ting; Wen-Che Chi; Cheng-Hao Lin; Yi-Chun Liu; Wan-Long Chuang
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

3.  Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing.

Authors:  Duo Li; Ling Zhang; Li Zuo; Cheng Gang Jin; Wen Ge Li; Jin-Bor Chen
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

4.  Aortic Arch Calcification as a Predictor of Repeated Arteriovenous Fistula Failure within 1-Year in Hemodialysis Patients.

Authors:  Yit-Sheung Yap; Kai-Ting Ting; Wen-Che Chi; Cheng-Hao Lin; Yi-Chun Liu; Po-Lin Kuo; Wan-Long Chuang
Journal:  Biomed Res Int       Date:  2017-05-31       Impact factor: 3.411

5.  Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis.

Authors:  Xiaohan You; Ying Zhou; Jianna Zhang; Qiongxiu Zhou; Yanling Shi; Zhen Su; Chaoshen Chen; Rongrong Shao; Ji Zhang
Journal:  BMC Nephrol       Date:  2020-05-18       Impact factor: 2.388

6.  Resistance to erythropoiesis-stimulating agents is associated with arterial microcalcification in early hemodialysis patients.

Authors:  Hye Sung Won; Su Jin Choi; Yu Seon Yun; Ok-Ran Shin; Yoon Ho Ko; Young Soo Kim; Sun Ae Yoon; Young Ok Kim
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

7.  Pulmonary hypertension in chronic kidney disease: what could change the fate?

Authors:  Soo Bong Lee
Journal:  Kidney Res Clin Pract       Date:  2015-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.